You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 1, January 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Endocrine Surgery
 •Diagnosis
 •Hematology/ Hematologic Malignancies
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic

Surgical Indications in Idiopathic Splenomegaly

John Alfred Carr, MD; Muhammad Shurafa, MD; Vic Velanovich, MD

Arch Surg. 2002;137:64-68.

Hypothesis  The incidence of primary lymphoma of the spleen in patients with idiopathic splenomegaly is significant.

Design  Retrospective review of all patients referred to a general surgical service for splenectomy.

Setting  A large tertiary care hospital.

Patients  Between 1994 and 2001, 86 nontrauma patients were referred for splenectomy. Of these, 18 had idiopathic splenomegaly despite prior workup with computed tomography, peripheral smear, bone marrow biopsy, and laboratory testing. All patients were symptomatic and displayed varying degrees of cytopenia.

Intervention  All 18 patients underwent open splenectomy for diagnosis and treatment of their cytopenias.

Main Outcome Measure  Incidence of lymphoma in the pathologic specimens.

Results  The mean size of the spleens was 21 cm (range, 14-34 cm) and mean weight was 996 g (range, 320-1840 g). In all 18 patients, the surgical speciman provided a diagnosis. Sarcoidosis was discovered in 4 patients, and 1 patient had Castleman disease. Six patients with the benign diagnosis of hypersplenism received no futher interventions, and the cytopenias resolved in all 6 cases. The 7 remaining patients (39%) were diagnosed with lymphoma. Five had marginal zone lymphoma, and 2 had a more aggressive B-cell lymphoma. Three patients required chemotherapy, but 4 are still in remission since their splenectomies and show no evidence of active disease. The mean follow-up was 20 months.

Conclusions  A high percentage of patients with splenomegaly of unknown etiology will have primary lymphoma of the spleen. Splenectomy is both diagnostic and therapeutic and should be considered for all patients with idiopathic splenomegaly.


From the Division of General Surgery (Drs Carr and Velanovich) and the Division of Hematology and Oncology (Dr Shurafa), Henry Ford Hospital, Detroit, Mich.


RELATED ARTICLES

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2002;137(1):116-117.
FULL TEXT  

Surgical Indications in Idiopathic Splenomegaly—Invited Critique
David W. McFadden
Arch Surg. 2002;137(1):68.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.